Resource Utilization and Outcomes in Patients with Atrial Fibrillation

By Boggon, Rachael; Lip, Gregory Yh et al. | Applied Health Economics and Health Policy, July 2012 | Go to article overview

Resource Utilization and Outcomes in Patients with Atrial Fibrillation


Boggon, Rachael, Lip, Gregory Yh, Gallagher, Arlene M., van Staa, Tjeerd P., Applied Health Economics and Health Policy


Key points for decision makers

* Estimates of resource utilization based on 'real world' clinical practice are required to evaluate the cost effectiveness of novel treatments for atrial fibrillation (AF)

* Resource utilization of GPs, hospitalizations and prescribing is significantly increased in AF patients compared with controls

* Increases in resource utilization were present across stroke risk categories and current (or past) use of warfarin or aspirin

* The mortality rate amongst patients with AF was 3-fold higher than controls, and the increase in risk was not restricted to cardiovascular deaths alone

Introduction

Atrial fibrillation (AF) is the most common sustained disorder of cardiac rhythm. The condition is associated with an increased mortality and morbidity from stroke, thromboembolism and heart failure.[1] The approach to management of AF emphasizes thromboprophylaxis, then consideration of rate or rhythm control, although this is largely symptom directed.[2]

Various new anticoagulation and antiarrythmic treatments are being investigated for the treatment of AF. Before novel treatments can be used widely in actual clinical practice, the cost effectiveness of such novel treatments may need to be determined. In England and Wales, formal cost-effectiveness analyses are now required and several years ago the National Institute for Health and Clinical Excellence (NICE) was established to balance the financial costs and clinical benefits of health technologies and evaluate their cost effectiveness.[3,4] Cost effectiveness is typically evaluated in models that vary treatment in a given scenario of drug effects, incidence rates of outcomes and costs. Randomized clinical trials (RCTs) are typically used not only for the estimate of drug effect but also for the absolute incidence rates.[5,6] Indeed, several cost-effectiveness analyses of treatments in AF used RCT data for incidence rates in the modelling.[7-12] Nonetheless, recent research has found that cost-effectiveness analyses based on RCTs may lack external validity, unless they reflect the experience of patients in actual 'real world' clinical practice.[13] One of the reasons for this is that patients in actual clinical practice may be different from those enrolled into RCTs and that incidence rates of outcomes may vary.

The objectives of this study were to describe the resource utilization (primary and secondary care) in AF and control patients in 'real world' clinical practice, and to describe the incidence rates of clinical outcomes and mortality and primary causes of death.

Patients and Methods

Data for this study were obtained from the General Practice Research Database (GPRD, April 2009 version, covering approximately 6% of the UK population). GPRD collates the computerized medical records of general practitioners (GPs). GPs play a key role in the UK healthcare system, as they are responsible for primary healthcare and specialist referrals. Patients are registered with one general practice that centralizes the medical information from the GPs, specialist referrals and hospitalizations. The data recorded in the GPRD include demographic information, prescription details, clinical events, preventive care provided, specialist referrals, hospital admissions and major outcomes. GPRD currently includes data on over 10 million patients and has been shown to be representative of the UK population.[14] GPRD patients in over 210 English practices are now linked individually and anonymously to the national registry of hospital admission (Hospital Episode Statistics [HES]) and to the death certificates (as collected by the Office of National Statistics [ONS]). For each hospitalized patient, the hospital charts are reviewed, dates of admission and discharge and main diagnoses are extracted, coded by coding staff and collated nationally. The death certificates list the date and causes of death. HES data were available from April 1997 and death certificate data from January 2001 for about 40% of GPRD practices and only those practices that had HES and ONS data available were included in this study. …

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Default project is now your active project.
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Resource Utilization and Outcomes in Patients with Atrial Fibrillation
Settings

Settings

Typeface
Text size Smaller Larger Reset View mode
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.